Guilford (GLFD) - Steadily Rising | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Guilford (GLFD) - Steadily Rising

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
496	22	0	GLFD

Emcee: Jim Ball	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
96	Guilford is in an interesting cross-current. I think it has excellent long ter	Czechsinthemail	-	9/14/1997
95	That is interesting! Announcement came on August 21th, which was a Friday I	tdinovo	-	9/14/1997
94	Insider selling at Guilford: 1 director sold 38,000 shares ($1,040,440) on 8/2	Czechsinthemail	-	9/14/1997
93	Boy, did anybody else just see that 60,000 share block trade at the ask (30.25)	tdinovo	-	9/9/1997
92	no need to re-type anything on our parts when you post a URL it becomes usable	henry jakala	-	9/9/1997
91	Ahh, so its taken care of automatically. Clever, these Californians!!!	tdinovo	-	9/9/1997
90	Well, here's what I got (same as last time), but at least you'll know w	tdinovo	-	9/9/1997
89	just cut and paste in the URL - we can take link from within the post directly	henry jakala	-	9/8/1997
88	To those interested, there a great little piece on Guilford in today's Wa	tdinovo	-	9/8/1997
87	GLFD has an honorable mention as being one of the currently favored biotech sto	henry jakala	-	9/5/1997
86	John, Disney in August is with young kids is not relaxing. Solace is found in	Vector1	-	9/3/1997
85	Greetings V1 and others, Back from my relaxing So. California trip (if you cal	John Dwyer	-	9/3/1997
84	Baird: Possible competition. Based on first class of the ligand GLFD patented.	Miljenko Zuanic	-	8/29/1997
83	mz, Nice to see you here. Do you see the issue between VRTX and GLFD as possi	Czechsinthemail	-	8/29/1997
82	does anyone have an explanation for todays high volumn..on no news!	ken carney	-	8/28/1997
81	Steve: I am not big believer in conference call or conversation with companies	Miljenko Zuanic	-	8/27/1997
80	<According to this press release and what is available in literature and in	SteveG	-	8/27/1997
79	Steve: >> But don't these compounds exhibit calcineurin inhibiting e	Miljenko Zuanic	-	8/27/1997
78	<Yes. VRTX patent (5,654,332) cover broad class of the N-1,2-diketo-(Y	SteveG	-	8/27/1997
77	Steve: Your explanation is simplified, but for now (until we see data prom pri	Miljenko Zuanic	-	8/25/1997
76	Congrats to all who had the foresight to buy Guilford. I happened to buy anoth	Marty	-	8/25/1997
75	<Any idea why GLFD tested GPI-1046 at 3 or 10 mg/kg (PNAS: s.c. injection wh	SteveG	-	8/25/1997
74	Any idea why GLFD tested GPI-1046 at 3 or 10 mg/kg (PNAS: s.c. injection which	Miljenko Zuanic	-	8/24/1997
73	<Obviously this is not an exact science and it's a difficult call for a	SteveG	-	8/24/1997
72	<They also have Dopascan (phase IIb data will be presented next month), seco	SteveG	-	8/24/1997

Go to reply# or date (mm/dd/yy):